|10 November, 2019

GSK Egypt to launch three new production lines in two years

Total investments of GSK Egypt amounted to $800mln

Image used for illustrative purpose. medicine chemical lab machine to pack and export for the pharmacy to medical for healthy.

Image used for illustrative purpose. medicine chemical lab machine to pack and export for the pharmacy to medical for healthy.

Getty Images

Cairo –  Glaxo SmithKline (GSK Egypt) aims to launch three new production lines valued at EGP 180 million in 2019 and 2020, the company’s general manager Amr Mamdouh said.

GSK Egypt’s new investments include EGP 100 million for opening two lines for the production of Voltaren in 2019 as well as EGP 80 million for launching a new production line at El-Salam factory in 2020, Mamdouh added in a statement released by the Egyptian Ministry of Investment and International Cooperation on Sunday.

Total investments of GSK Egypt amounted to $800 million injected into ten factories, he noted.

It is noteworthy that during the first quarter of 2019, GSK Egypt incurred consolidated net losses of EGP 7.55 million, against net profits of EGP 22.07 million in the year-ago period, including minority shareholders’ rights.

Source: Mubasher

All Rights Reserved - Mubasher Info © 2005 - 2019 Provided by SyndiGate Media Inc. (Syndigate.info).

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.

More From Business